|
|
||||||||
The Journal of Immunology, Vol 154, Issue 11 5656-5664, Copyright © 1995 by American Association of Immunologists
ARTICLES |
JD Gray and DA Horwitz
Department of Medicine, University of Southern California, School of Medicine, Los Angeles 90033, USA.
In addition to their cytotoxic function, NK cells can either suppress or enhance Ab production. Upon activation, NK cells generally amplify Ig secretion by activated B cells. We now report that activated NK cells prepared from human peripheral blood can induce resting B cells to produce IgM and IgG. This was demonstrated by adding IL-2 or pokeweed mitogen to purified NK cells and B cells. The addition of IL-2- activated NK cells to B cells also had this effect. The responding B cells did not require activation. Moreover, following fractionation of B cells on Percoll gradients, responsive B cells were found in the high density as well as the low density fractions. The NK cell stimulatory effect was a two-step process. The first step induced B cells to respond to soluble mediators and was mediated by unstimulated NK cells, but not CD4 nor CD8 T cells. Physical contact between NK cells and B cells was required, and mAbs to CD11a and CD54 blocked this interaction. The second step was the production of as yet unidentified cytokine(s) by activated NK cells. These direct T cell-independent stimulatory effects of NK cells on B cells may be important in autoimmune and other chronic inflammatory diseases in which the suppressive effects of NK cells may be blocked.
This article has been cited by other articles:
![]() |
G. Galli, P. Pittoni, E. Tonti, C. Malzone, Y. Uematsu, M. Tortoli, D. Maione, G. Volpini, O. Finco, S. Nuti, et al. Invariant NKT cells sustain specific B cell responses and memory PNAS, March 6, 2007; 104(10): 3984 - 3989. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Nowbakht, M.-C. S. Ionescu, A. Rohner, C. P. Kalberer, E. Rossy, L. Mori, D. Cosman, G. De Libero, and A. Wodnar-Filipowicz Ligands for natural killer cell-activating receptors are expressed upon the maturation of normal myelomonocytic cells but at low levels in acute myeloid leukemias Blood, May 1, 2005; 105(9): 3615 - 3622. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Gao, T. Dang, W. A. Dunnick, J. T. Collins, B. R. Blazar, and D. Yuan Receptors and Counterreceptors Involved in NK-B Cell Interactions J. Immunol., April 1, 2005; 174(7): 4113 - 4119. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Assarsson, T. Kambayashi, J. D. Schatzle, S. O. Cramer, A. von Bonin, P. E. Jensen, H.-G. Ljunggren, and B. J. Chambers NK Cells Stimulate Proliferation of T and NK Cells through 2B4/CD48 Interactions J. Immunol., July 1, 2004; 173(1): 174 - 180. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Yuan, R. Bibi, and T. Dang The role of adjuvant on the regulatory effects of NK cells on B cell responses as revealed by a new model of NK cell deficiency Int. Immunol., May 1, 2004; 16(5): 707 - 716. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Costa, D. F. Barber, and W. L. Fodor Human NK Cell-Mediated Cytotoxicity Triggered by CD86 and Gal{alpha}1,3-Gal Is Inhibited in Genetically Modified Porcine Cells J. Immunol., April 15, 2002; 168(8): 3808 - 3816. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. R. Blanca, E. W. Bere, H. A. Young, and J. R. Ortaldo Human B Cell Activation by Autologous NK Cells Is Regulated by CD40-CD40 Ligand Interaction: Role of Memory B Cells and CD5+ B Cells J. Immunol., December 1, 2001; 167(11): 6132 - 6139. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Almeida, R. M. Andrade, and C. A. M. Bento The Capsular Polysaccharides of Cryptococcus neoformans Activate Normal CD4+ T Cells in a Dominant Th2 Pattern J. Immunol., November 15, 2001; 167(10): 5845 - 5851. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Satoskar, L. M. Stamm, X. Zhang, M. Okano, J. R. David, C. Terhorst, and B. Wang NK Cell-Deficient Mice Develop a Th1-Like Response but Fail to Mount an Efficient Antigen-Specific IgG2a Antibody Response J. Immunol., November 15, 1999; 163(10): 5298 - 5302. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. B. de Arruda Hinds, L. M. Previato, J. O. Previato, Q. Vos, J. J. Mond, and L. M. T. Pecanha Modulation of B-Lymphocyte and NK Cell Activities by Glycoinositolphospholipid Purified from Trypanosoma cruzi Infect. Immun., November 1, 1999; 67(11): 6177 - 6180. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Satoskar, L. M. Stamm, X. Zhang, A. A. Satoskar, M. Okano, C. Terhorst, J. R. David, and B. Wang Mice Lacking NK Cells Develop an Efficient Th1 Response and Control Cutaneous Leishmania major Infection J. Immunol., June 1, 1999; 162(11): 6747 - 6754. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Gonzalez-Cabrero, C. J. Wise, Y. Latchman, G. J. Freeman, A. H. Sharpe, and H. Reiser CD48-deficient mice have a pronounced defect in CD4+ T cell activation PNAS, February 2, 1999; 96(3): 1019 - 1023. [Abstract] [Full Text] [PDF] |
||||
![]() |
K Ohtsuka, J D Gray, F P Quismorio Jr, W Lee, and D A Horwitz Cytokine-mediated down-regulation of B cell activity in SLE: effects of interleukin-2 and transforming growth factor-beta Lupus, February 1, 1999; 8(2): 95 - 102. [Abstract] [PDF] |
||||
![]() |
Q. Vos, C. M. Snapper, and J. J. Mond Heterogeneity in the ability of cytotoxic murine NK cell clones to enhance Ig secretion in vitro Int. Immunol., February 1, 1999; 11(2): 159 - 168. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hoshino, R. T. Winkler-Pickett, A. T. Mason, J. R. Ortaldo, and H. A. Young IL-13 Production by NK Cells: IL-13-Producing NK and T Cells Are Present In Vivo in the Absence of IFN-{gamma} J. Immunol., January 1, 1999; 162(1): 51 - 59. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Latchman, P. F. McKay, and H. Reiser Cutting Edge: Identification of the 2B4 Molecule as a Counter-Receptor for CD48 J. Immunol., December 1, 1998; 161(11): 5809 - 5812. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Carbone, G. Ruggiero, G. Terrazzano, C. Palomba, C. Manzo, S. Fontana, H. Spits, K. Karre, and S. Zappacosta A New Mechanism of NK Cell Cytotoxicity Activation: The CD40-CD40 Ligand Interaction J. Exp. Med., June 16, 1997; 185(12): 2053 - 2060. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |